Catalyst Pharmaceuticals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Catalyst Pharmaceuticals Inc (Catalyst) is a biopharmaceutical company that develops prescription drugs targeting rare neurological and neuromuscular diseases. The company focuses on specific conditions such as infantile spasms, complex partial seizures, Lambert-Eaton myasthenic syndrome (LEMS), congenital myasthenic syndromes (CMS), downbeat nystagmus and Tourette syndrome. Its product portfolio includes Firdapse, a proprietary form of amifampridine phosphate for the treatment of LEMS, CMS and myasthenia gravis; CPP-115, a GABA aminotransferase inhibitor for central nervous system (CNS) indications, such as infantile spasms, epilepsy and Tourette syndrome; and CPP-109, a generic version of Sabril for Tourette’s disorder. The company operates in the US and through its subsidiary in Ireland. Catalyst is headquartered in Coral Gables, Florida, the US.
Scope
- Detailed information on Catalyst Pharmaceuticals Inc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Catalyst Pharmaceuticals Inc in the form of a SWOT analysis
- An in-depth view of the business model of Catalyst Pharmaceuticals Inc including a breakdown and examination of key business segments
- News about Catalyst Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Catalyst Pharmaceuticals Inc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Catalyst Pharmaceuticals Inc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Catalyst Pharmaceuticals Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
ReceptoPharm Inc
Psyadon Pharmaceuticals Inc
Marinus Pharmaceuticals Inc
Marathon Pharmaceuticals LLC
Jacobus Pharmaceutical Co Inc
GlaxoSmithKline Plc
ReceptoPharm Inc
Psyadon Pharmaceuticals Inc
Marinus Pharmaceuticals Inc
Marathon Pharmaceuticals LLC
Jacobus Pharmaceutical Co Inc
GlaxoSmithKline Plc
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Catalyst Pharmaceuticals Inc - Key Facts
Catalyst ...
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
Catalyst Pharmaceuticals Inc - Key Facts
Catalyst Pharmaceuticals Inc - Key Employees
Catalyst Pharmaceuticals Inc - Key Employee Biographies
Catalyst Pharmaceuticals Inc - Major Products and Services
Catalyst Pharmaceuticals Inc - History
Catalyst Pharmaceuticals Inc - Company Statement
Catalyst Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Catalyst Pharmaceuticals Inc - Business Description
Catalyst Pharmaceuticals Inc - Corporate Strategy
Catalyst Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Catalyst Pharmaceuticals Inc - Strengths
Catalyst Pharmaceuticals Inc - Weaknesses
Catalyst Pharmaceuticals Inc - Opportunities
Catalyst Pharmaceuticals Inc - Threats
Catalyst Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Catalyst Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 07, 2019: Catalyst Pharmaceuticals announces second quarter 2019 financial results and provides corporate update
May 13, 2019: Catalyst Pharmaceuticals announces first quarter 2019 financial results and provides corporate updatea
Mar 18, 2019: Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2018 Financial Results and Provides Corporate Update
Feb 05, 2019: US Senate invites seven pharma majors to testify on price hikes
Nov 07, 2018: Catalyst Pharmaceuticals announces third quarter 2018 financial results and provides corporate update
Aug 20, 2018: Catalyst Pharmaceuticals names Dr. Stanley Iyadurai as vice president of clinical development
Aug 07, 2018: Catalyst Pharmaceuticals Announces Second Quarter 2018 Financial Results and Provides Corporate Update
Aug 06, 2018: Catalyst Pharmaceuticals expands commercial leadership team
May 23, 2018: CENTOGENE Announces Drug Development Collaboration with Orphazyme in Neuronopathic Gaucher Disease
May 09, 2018: Catalyst Pharmaceuticals Announces First Quarter 2018 Financial Results and Provides Corporate Update
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
List of Tables
Catalyst Pharmaceuticals Inc, Key Facts
Catalyst Pharmaceuticals Inc, Key Employees
Catalyst Pharmaceuticals Inc, Key Employee Biographies
Catalyst Pharmaceuticals Inc, Major Products and ...
List of Tables
Catalyst Pharmaceuticals Inc, Key Facts
Catalyst Pharmaceuticals Inc, Key Employees
Catalyst Pharmaceuticals Inc, Key Employee Biographies
Catalyst Pharmaceuticals Inc, Major Products and Services
Catalyst Pharmaceuticals Inc, History
Catalyst Pharmaceuticals Inc, Subsidiaries
Catalyst Pharmaceuticals Inc, Key Competitors
Catalyst Pharmaceuticals Inc, Ratios based on current share price
Catalyst Pharmaceuticals Inc, Annual Ratios
Catalyst Pharmaceuticals Inc, Annual Ratios (Cont...1)
Catalyst Pharmaceuticals Inc, Interim Ratios
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Catalyst Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
List of Figures
Catalyst Pharmaceuticals Inc, Performance Chart (2014 - 2018)
Catalyst Pharmaceuticals Inc, Ratio Charts
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, ...
List of Figures
Catalyst Pharmaceuticals Inc, Performance Chart (2014 - 2018)
Catalyst Pharmaceuticals Inc, Ratio Charts
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Catalyst Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019